title: Renal-Cell Cancer--Targeting an Immune Checkpoint or Multiple Kinases.
authors.affiliation: From the University of Southern California Norris Comprehensive Cancer Center, Los Angeles (D.I.Q.), and the University of California Davis Comprehensive Cancer Center, Sacramento (P.N.L.).
authors.forename: David I
authors.initials: DI
authors.lastname: Quinn
authors.forename: Primo N
authors.initials: PN
authors.lastname: Lara
mesh_terms: D000813:Anilides / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D011725:Pyridines / Q000627:therapeutic use*; D020123:Sirolimus / Q000031:analogs & derivatives*
chemical_list: D000813:Anilides; D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D011725:Pyridines; D020123:Sirolimus